Posted on April 10, 20264/10/26
Stay Ahead of Change with NAVLIN Daily’s Global Policy Watch
Posted on March 13, 20263/13/26
Webinar Recording | From MFPs to MFN: Navigating the New Rules of Drug Pricing in 2026
Posted on January 27, 20261/27/26
Insights from Frontiers Health 2025: How European Biotechs Can Navigate the U.S. Market
Posted on January 14, 20261/14/26
The Combination Crossfire: Is Your Brand Strategy Strong Enough to Align Payers, Prescribers, and Patients?
Posted on January 14, 20261/14/26
NAVLIN Daily 2025 Round-Up: The Pricing and Policy Trends Redefining Market Access
Posted on January 5, 20261/5/26
A New Marketing Mandate in Community Oncology
Posted on December 17, 202512/17/25
The Enablement Helix: An Evolving Framework for Market Success in Oncology
Posted on December 10, 202512/10/25
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Posted on December 3, 202512/3/25
New Direct-to-Employer Access Model Provides Options for Employers to Improve Access to Weight Loss Medications
Posted on October 16, 202510/16/25